This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Top Swing Trade Ideas for Tuesday, August 19: Apple, Zynga, More

Stocks in this article: AAPL AMRN ZNGA

NEW YORK (TheStreet) -- Good day traders!

Today's top swing picks are Apple (APPL) , Amarin (AMRN) and Zynga (ZNGA) .

Read More: 10 Stocks Carl Icahn Loves in 2014

1. First, let's look at the mega-awesome computer and phone manufacturer, Apple.

Apple traded up 1.20% on Monday, closing at $99.16

  • Monday's range: $97.98 - $99.37
  • 52-week range: $63.89 - $99.44
  • Monday's volume: 46,471,236
  • 3-month average volume: 53,710,300

Apple looks great at this level -- it is sitting right at a breakout level. Yesterday completed the two-candlestick signal, the doji gap-up. The doji gap-up is a great pattern to trade, as it has great upside potential. (A doji chart has a stock price that opens and closes in almost the same spot, but it may be wide-ranging in price over the course of the day.) Shares are trading up after bouncing off the 50-day simple moving average on Aug. 8. The stock chart formed the perfect hammer candlestick signal, which told us that the bottom has been reached. Now I'd like to see a break above the 52-week high of $99.44.

My trade plan for Apple would be to enter a position as low as you can get in -- an inside day entry would be great, but unlikely. I like an entry between $97.53 and $99.16. I'd set a stop just below the t-line, at about $97.00. I will target the top of the previous trend channel, and look to add to my position on pullbacks like we are experiencing right now. Once the top of the trend channel is reached, I will take partial profits, and buy on the next dip.

Stay long until you see a confirmed sell signal or a close below the t-line.

2. Now, let's look at Amarin, a biopharmaceutical company focused on the development and commercialization of therapeutic products for the treatment for cardiovascular diseases in the U.S.

Amarin traded up 2.17% on Monday, closing at $1.86.

  • Monday's range: $1.79 - $1.88
  • 52-week range: $1.28 - $7.40
  • Monday's volume: 3,536,338
  • 3-month average volume: 1,948,880

Amarin looks like a good swing trade for its gain potential in a short period. Share price is up 46% from its 52-week low that was reached back in the end of May. Price action has been slowly and steadily trading up. Then it pulled back, and now it is trading over the major moving averages. Last Thursday, Amarin had a big day, trading up nearly 12%, then formed a couple of dojis, which is a nice continuation pattern and confirmation of the bullish trade. Yesterday formed a bullish engulfing signal, and will likely trade higher today.

Read More: No Reason for Penney to Exist; Party On, Biotech: Jim Cramer's Best Blogs

Amarin is a penny stock, so a lot of folks don't care for trading these types of stocks, but this has great return potential.

My trade plan would be to enter a position between $1.75 and yesterday's high. I'd set a stop at about $1.70, which is the 200-day simple moving average. I would target the overhead resistance levels. Stay long until you see a confirmed sell signal or a close below the t-line.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs